X53: (2S,4R)-1-[(2R)-2-[3-[4-[(3S)-4-[4-[5-[(4S)-2-azanyl-3-cyano-4-methyl-6,7-dihydro-5H-1-benzothiophen-4-yl]-1,2,4-oxadiazol-3-yl]pyrimidin-2-yl]-3-methyl-1,4-diazepan-1-yl]butoxy]-1,2-oxazol-5-yl]-3-methyl-butanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide
X53 is a Ligand Of Interest in 9RKE designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 9RKE_X53_D_201 | 88% | 55% | 0.083 | 0.957 | 0.9 | 0.84 | 4 | 3 | 2 | 0 | 100% | 1 |
| 9RKE_X53_H_201 | 77% | 55% | 0.104 | 0.943 | 0.89 | 0.84 | 4 | 3 | 1 | 0 | 100% | 1 |
| 8QW7_X53_B_401 | 65% | 4% | 0.15 | 0.952 | 4.04 | 1.81 | 18 | 14 | 6 | 0 | 100% | 1 |
